BBLG
Bone Biologics Corporation
NASDAQ · Healthcare · Medical - Devices · US
$0.56
+0.39%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-55.2%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jan 21, 2026 | Walsh Deina H · officer: Chief Financial Officer | A-Award | 8,335 | $1.55 |
| Jan 21, 2026 | Frelick Jeff · officer: Chief Executive Officer | A-Award | 16,668 | $1.55 |
| Jun 6, 2025 | Meikle Phillip Terry II · director | A-Award | 62,894 | $0.88 |
| Jun 6, 2025 | Angle Siddhesh Rajendra · director | A-Award | 62,894 | $0.88 |
| Jun 6, 2025 | Stroever Bruce · director | A-Award | 62,894 | $0.88 |
| Jun 6, 2025 | Gagnon Robert E. · director | A-Award | 62,894 | $0.88 |
| Jan 21, 2025 | Frelick Jeff · officer: Chief Executive Officer | A-Award | 54,110 | $0.97 |
| Jan 21, 2025 | Walsh Deina H · officer: Chief Financial Officer | A-Award | 27,055 | $0.97 |
| Oct 18, 2024 | Meikle Phillip Terry II · director | A-Award | 28,185 | $1.88 |
| Oct 18, 2024 | Meikle Phillip Terry II · director | A-Award | 9 | $1.88 |
| Sep 19, 2024 | Stroever Bruce · director | A-Award | 30,713 | $1.73 |
| Sep 19, 2024 | Gagnon Robert E. · director | A-Award | 30,713 | $1.73 |
| Sep 19, 2024 | Angle Siddhesh Rajendra · director | A-Award | 30,713 | $1.73 |
| Jan 19, 2024 | Walsh Deina H · officer: Chief Financial Officer | A-Award | 12,500 | $3.61 |
| Jan 19, 2024 | Frelick Jeff · officer: Chief Executive Officer | A-Award | 25,000 | $3.61 |
| Jan 10, 2024 | Gagnon Robert E. · director | A-Award | 8 | $4.68 |
| Jan 10, 2024 | Gagnon Robert E. · director | A-Award | 9 | $4.68 |
| Sep 20, 2023 | Lucera Erick · director | A-Award | 85,763 | $0.64 |
| Sep 20, 2023 | Angle Siddhesh Rajendra · director | A-Award | 85,763 | $0.64 |
| Sep 20, 2023 | Stroever Bruce · director | A-Award | 85,763 | $0.64 |
| Sep 14, 2023 | Walsh Deina H · officer: Chief Financial Officer | Purchase | 8,000 | $0.64 |
| Sep 12, 2023 | Frelick Jeff · officer: Chief Executive Officer | Purchase | 9,500 | $0.69 |
| Sep 7, 2023 | Walsh Deina H · officer: Chief Financial Officer | Purchase | 6,700 | $0.71 |
| Sep 7, 2023 | Walsh Deina H · officer: Chief Financial Officer | Purchase | 300 | $0.70 |
| Sep 5, 2023 | Frelick Jeff · officer: Chief Executive Officer | Purchase | 7,600 | $0.66 |
| Mar 8, 2023 | Angle Siddhesh Rajendra · director | A-Award | 36,845 | $1.61 |
| Mar 8, 2023 | Stroever Bruce · director | A-Award | 36,845 | $1.61 |
| Mar 8, 2023 | Frelick Jeff · officer: Chief Executive Officer | A-Award | 37,750 | $0.24 |
| Mar 8, 2023 | Lucera Erick · director | A-Award | 36,845 | $1.61 |
| Mar 8, 2023 | Walsh Deina H · officer: Chief Financial Officer | A-Award | 18,875 | $0.24 |
Institutional positioning
13F filings over the trailing two quarters
New 1Increased 1Reduced 1Sold out 3
| Filer | Action | Shares | Filed |
|---|---|---|---|
| CITADEL ADVISORS LLC | New Position | 23,879 | Sep 2, 2026 |
| TOWER RESEARCH CAPITAL LLC (TRC) | Increased | 4,126 | May 15, 2026 |
| SBI SECURITIES CO., LTD. | Unchanged | 230 | Apr 28, 2026 |
| UBS GROUP AG | Reduced | 56 | May 5, 2026 |
| SBI Securities Co., Ltd. | Sold Out | 0 | Apr 28, 2026 |
| Tower Research Capital LLC (TRC) | Sold Out | 0 | May 15, 2026 |
| UBS Group AG | Sold Out | 0 | May 5, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jan 21, 2026